Sun Pharmaceuticals reported INR24.89B in Selling and Administration Expenses for its fiscal quarter ending in March of 2025.





Selling And Administration Expenses Change Date
Aspen Pharmacare ZAR 4.35B 1.28B Dec/2025
Bharat Petroleum INR 8.66B 88.2M Dec/2025
Cipla INR 13.25B 101.8M Dec/2025
Dr.Reddys Laboratories INR 26.92B 482M Dec/2025
Jiangsu Hengrui CNY 2.81B 191.05M Mar/2026
Sh Fosun Pharma CNY 3.27B 1.17B Mar/2026
Sun Pharmaceuticals INR 24.89B 637.6M Mar/2025
UPL INR 15.8B 660M Sep/2025